SlideShare a Scribd company logo
PERFORMANCE
EVALUATION METHODS
In-vitro Dissolution, Bioavailability, Bio equivalence,
Evaluation
In-vitro dissolution studies
Noyes- Whitney
Equation
Interpretation of
Dissolution Data
Factors affecting dissolution rate
 1. Disintegration is the important first step to drug dissolution in a tablet.
 2. Particle size of drug substance.
 3. Solubility and hydrophobicity of the drug; type and amount of disintegrant, diluent,
binder, lubricant, glidant and the coating type and thickness.
 4. Solubility and dissolution also influenced by pH of the media, media composition,
change in the crystalinity of drug, temperature, paddle speed.
 5. Manufacturing method (compactness of the granulation and compression force
used in tableting)
Dissolution Apparatus
Types:
On basis of USP
- Similarity and Dissimilarity Factor
Dissolution test apparatus
Stirrer shaft
Paddle Thermostated water bath
Glass vessel
USP apparatus II
Glass vessel 1000 ml volumeCylindrical Stainless
steal Basket formed
from a screen
Paddle
(USP apparatus II)
Stirrer shaft
Stirred vessel method
Basket type Paddle type
Media used in dissolution test:
- Purified water.
- Simulated gastric fluid.
- Simulated intestinal fluid.
- Solvents mixture may be used if the drug solubility is very low.
 Dissolution test is performed in-process and on the final product.
Bioavailability studies and bioavailability testing protocol and
procedures
Bioavailability - Bioequivalence
Bioavailability
Bioavailability is a pharmacokinetic
term that describes the rate and
extent to which the active drug
ingredient is absorbed from a drug
product and becomes available at
the site of drug action.
Why?
 Pharmacologic response is
generally related to the
concentration of drug at the
receptor site
 Quantity of Drugs in
blood/Urine need to be
estimated
 Assumption- Drug
concentration in blood is
equivalent to receptor site
concentration
Absolute Bioavailability
 Tofraction of an
administered dose which
actually reaches the
systemic circulation
 Denoted by F
 Ranges from F = 0 (no
drug absorption) to F = 1
(complete drug
absorption).
Relative Bioavailability
 Availability of a drug product
as compared to another
dosage form or product of the
same drug given in the same
dose.
 The relative bioavailability of
product A compared to
product B, both products
containing the same dose of
the same drug, is obtained by
comparing their respective
Relative Bioavailability
 When the bioavailability of
a generic product is
considered, it is usually the
relative bioavailability that
is referred to. A more
general form of the
equation results from
considering the possibility
of different doses:
Example
Factors affecting Bioavaliability
 disintegration of the drug product
 dissolution of the drug in the fluids at the
absorption site
 transfer of drug molecule across the
membrane lining the gastrointestinal tract into
the systemic circulation.
Factors affecting Bio-avaliability
Factors affecting Bio-avaliability
Bio-avaliability vs Rate of
absorption
 aqueous solution > aqueous suspension >
capsule> tablet > Controlled Released
Methods of assessing bioavailability-
Predicting Clinical efficacy
 Pharmacokinetics
 Pharmacodynamics
Methods of assessing bioavailability-
Predicting Clinical efficacy
 In vivo:
Single dose
Normal/healthy adult
Clinical performance- Large test population
Need to be validated,
Methods of assessing bioavailability-
Predicting Clinical efficacy
 Blood sampling
Parameters
1. AUC , The area under the plasma concentration-time curve, The
AUC is proportional to the total amount of drug reaching the
systemic circulation, and thus characterizes the extent of
absorption.
2. Cmax , The maximum drug concentration. The maximum
concentration of drug in the plasma is a function of both the rate
and extent of absorption. Cmax will increase with an increase in
the dose, as well as with an increase in the absorption rate.
3. Tmax , The time at which the Cmax occurs. The Tmax reflects the
rate of drug absorption, and decreases as the absorption rate
increases.
Methods of assessing bioavailability-
Predicting Clinical efficacy
 Urinary Excretion Data
-determination of the total quantity of drug excreted in the urine as a function
of time
- urinary excretion of the unchanged drug is directly proportional to the
plasma concentration of total drug.
- Consider the following example: two products, A and B, each containing
100 mg of the same drug are administered orally. A total of 80 mg of drug is
recovered in the urine from Product A, but only 40 mg is recovered from
Product B. This indicates that twice as much drug was absorbed from
Product A as from Product B. (The fact that neither product resulted in
excretion of the entire dose might be due to the existence of other routes of
elimination, e.g. metabolism).
Methods of assessing bioavailability-
Predicting Clinical efficacy
 Urinary Excretion Data
1. the fraction of drug entering the bloodstream
and being excreted intact by the kidneys
must remain constant.
2. collection of the urine has to continue until all
the drug has been completely excreted (five
times the half-life ).
Parameters for Urinary Excretion
1. Maximum urinary excretion
rate
2. Time for Maximum excretion
rate
3. Cumulative amount of Drug
excreted
 The assessment o bioavailability by urinary
excretion is based on the assumption that the
appearance of the drug and/ or its metabolites in
the urine is a function of the rate and extent o
absorption. This assumption is only valid when a
drug and/ or its metabolites are extensively
excreted in the urine, and where the rate of
urinary excretion is proportional to the
concentration o the intact drug in the blood
plasma.
Urinary Data
This proportionality does not hold
if:
 the drug and/ or its metabolites are excreted
by an active transport process into the distal
kidney tubule
 the intact drug and/ or its metabolites are
weakly acidic or weakly basic (i.e. their rate of
excretion is dependent on urine pH)
 the excretion rate depends on the rate o urine
flow.
Interpretation: Plasma concentration-time curves for three different
formulations of the same drug administered in equal single doses by the same
extravascular route.
Bio-Equivalence
Biopharmaceutics Classification
System
 Class I – high solubility/ high permeability
 Class II – low solubility/ high permeability
 Class III – high solubility/ low permeability
 Class IV – low solubility/ low permeability.
Topic End

More Related Content

What's hot

Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
DhanshreeBhattad
 
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
JAYACHANDRA AKUTHOTA
 
Supac
SupacSupac
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval
Namdeo Shinde
 
Pilot plant scale up for tablets
Pilot plant scale up for tabletsPilot plant scale up for tablets
Pilot plant scale up for tablets
Robin Gulati
 
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCTCopp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Suraj Pamadi
 
Code of Federal Regulations
Code of Federal RegulationsCode of Federal Regulations
Code of Federal Regulations
Swapnil Fernandes
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. ppt
PRABU12345678
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptx
Roshan Yadav
 
Technology development & transfer by devill
Technology development & transfer by devillTechnology development & transfer by devill
Technology development & transfer by devill
Snake EYE
 
FDA Data Standards An Update
FDA Data Standards An UpdateFDA Data Standards An Update
FDA Data Standards An Update
shakulbio
 
Bioequivalence Studies
Bioequivalence StudiesBioequivalence Studies
Bioequivalence Studies
wonderingsoul114
 
Evaluation of transdermal drug delivery system
Evaluation of transdermal drug delivery systemEvaluation of transdermal drug delivery system
Evaluation of transdermal drug delivery system
Sagar Savale
 
Investigational new drug application (ind)
Investigational new drug application (ind)Investigational new drug application (ind)
Investigational new drug application (ind)
Siddu K M
 
Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...
Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...
Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...
PRAJAKTASAWANT33
 
Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)
Himal Barakoti
 
Regulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalRegulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug Approval
Shagufta Farooqui
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
Jamia Hamdard
 
In vitro dissolution testing methods
In vitro dissolution testing methodsIn vitro dissolution testing methods
In vitro dissolution testing methods
PNMallikarjun
 
Consolidation parameter
Consolidation parameterConsolidation parameter
Consolidation parameter
Kahnu charan panigrahi
 

What's hot (20)

Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
 
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
 
Supac
SupacSupac
Supac
 
Regulatory requirements for drug approval
Regulatory requirements for drug approval Regulatory requirements for drug approval
Regulatory requirements for drug approval
 
Pilot plant scale up for tablets
Pilot plant scale up for tabletsPilot plant scale up for tablets
Pilot plant scale up for tablets
 
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCTCopp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
 
Code of Federal Regulations
Code of Federal RegulationsCode of Federal Regulations
Code of Federal Regulations
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. ppt
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptx
 
Technology development & transfer by devill
Technology development & transfer by devillTechnology development & transfer by devill
Technology development & transfer by devill
 
FDA Data Standards An Update
FDA Data Standards An UpdateFDA Data Standards An Update
FDA Data Standards An Update
 
Bioequivalence Studies
Bioequivalence StudiesBioequivalence Studies
Bioequivalence Studies
 
Evaluation of transdermal drug delivery system
Evaluation of transdermal drug delivery systemEvaluation of transdermal drug delivery system
Evaluation of transdermal drug delivery system
 
Investigational new drug application (ind)
Investigational new drug application (ind)Investigational new drug application (ind)
Investigational new drug application (ind)
 
Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...
Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...
Non clinical drug development (Investigational Medicinal Product, IMPD) By Pr...
 
Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)
 
Regulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug ApprovalRegulatory Requirements For New Drug Approval
Regulatory Requirements For New Drug Approval
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
 
In vitro dissolution testing methods
In vitro dissolution testing methodsIn vitro dissolution testing methods
In vitro dissolution testing methods
 
Consolidation parameter
Consolidation parameterConsolidation parameter
Consolidation parameter
 

Similar to In vitro Performance evaluation methods of Tablets

BIO AVAILABILITY & Bio equivalence.pptx
BIO AVAILABILITY & Bio equivalence.pptxBIO AVAILABILITY & Bio equivalence.pptx
BIO AVAILABILITY & Bio equivalence.pptx
MANSISONI146297
 
Bio availability and bio equivalence
Bio availability and bio equivalenceBio availability and bio equivalence
Bio availability and bio equivalence
Malla Reddy College of Pharmacy
 
Bioavailability
Bioavailability Bioavailability
Bioavailability
SURYAKANTVERMA2
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
Ayanpal33
 
BioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdfBioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdf
abhisheksinghcompute
 
Bioavailability_and_Bioequivalence method
Bioavailability_and_Bioequivalence methodBioavailability_and_Bioequivalence method
Bioavailability_and_Bioequivalence method
ssuser7add2a
 
Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies
ROHIT
 
Bioavailabilityand bioequivalence
Bioavailabilityand bioequivalenceBioavailabilityand bioequivalence
Bioavailabilityand bioequivalence
harvestmoneyonline makemoney
 
GP-Bioavailability.pdf
GP-Bioavailability.pdfGP-Bioavailability.pdf
GP-Bioavailability.pdf
SanjayaManiDixit
 
Bioavailability, Bioequivalence and BCS Classification
Bioavailability, Bioequivalence and BCS ClassificationBioavailability, Bioequivalence and BCS Classification
Bioavailability, Bioequivalence and BCS Classification
Vignan University
 
Bioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence pptBioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence ppt
Aditya Sharma
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
Changbaeg Lim
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
Changbaeg Lim
 
Estimation of pharmacokinetic parameters
Estimation of pharmacokinetic parametersEstimation of pharmacokinetic parameters
Estimation of pharmacokinetic parameters
Karun Kumar
 
Pharmacokinetics of drugs , detailes of drug ADME.pptx
Pharmacokinetics of drugs , detailes of drug ADME.pptxPharmacokinetics of drugs , detailes of drug ADME.pptx
Pharmacokinetics of drugs , detailes of drug ADME.pptx
Haftom Gebregergs Hailu
 
bio availability
bio availabilitybio availability
bio availability
Prem Sai
 
Bioavailibility 112070804016
Bioavailibility  112070804016Bioavailibility  112070804016
Bioavailibility 112070804016
Patel Parth
 
Bioavailability & Bioequivalance
Bioavailability & BioequivalanceBioavailability & Bioequivalance
Drug Bio-availability.pdf
Drug Bio-availability.pdfDrug Bio-availability.pdf
Drug Bio-availability.pdf
IshaGumber1
 
1.0.bioavailability, pharmacokinetics and efficacy determination
1.0.bioavailability, pharmacokinetics and efficacy determination1.0.bioavailability, pharmacokinetics and efficacy determination
1.0.bioavailability, pharmacokinetics and efficacy determination
salummkata1
 

Similar to In vitro Performance evaluation methods of Tablets (20)

BIO AVAILABILITY & Bio equivalence.pptx
BIO AVAILABILITY & Bio equivalence.pptxBIO AVAILABILITY & Bio equivalence.pptx
BIO AVAILABILITY & Bio equivalence.pptx
 
Bio availability and bio equivalence
Bio availability and bio equivalenceBio availability and bio equivalence
Bio availability and bio equivalence
 
Bioavailability
Bioavailability Bioavailability
Bioavailability
 
Bioavailability ppt
Bioavailability pptBioavailability ppt
Bioavailability ppt
 
BioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdfBioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdf
 
Bioavailability_and_Bioequivalence method
Bioavailability_and_Bioequivalence methodBioavailability_and_Bioequivalence method
Bioavailability_and_Bioequivalence method
 
Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies Bioavailability and bioequivalance studies
Bioavailability and bioequivalance studies
 
Bioavailabilityand bioequivalence
Bioavailabilityand bioequivalenceBioavailabilityand bioequivalence
Bioavailabilityand bioequivalence
 
GP-Bioavailability.pdf
GP-Bioavailability.pdfGP-Bioavailability.pdf
GP-Bioavailability.pdf
 
Bioavailability, Bioequivalence and BCS Classification
Bioavailability, Bioequivalence and BCS ClassificationBioavailability, Bioequivalence and BCS Classification
Bioavailability, Bioequivalence and BCS Classification
 
Bioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence pptBioavailability & Bioequivalence ppt
Bioavailability & Bioequivalence ppt
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
 
Estimation of pharmacokinetic parameters
Estimation of pharmacokinetic parametersEstimation of pharmacokinetic parameters
Estimation of pharmacokinetic parameters
 
Pharmacokinetics of drugs , detailes of drug ADME.pptx
Pharmacokinetics of drugs , detailes of drug ADME.pptxPharmacokinetics of drugs , detailes of drug ADME.pptx
Pharmacokinetics of drugs , detailes of drug ADME.pptx
 
bio availability
bio availabilitybio availability
bio availability
 
Bioavailibility 112070804016
Bioavailibility  112070804016Bioavailibility  112070804016
Bioavailibility 112070804016
 
Bioavailability & Bioequivalance
Bioavailability & BioequivalanceBioavailability & Bioequivalance
Bioavailability & Bioequivalance
 
Drug Bio-availability.pdf
Drug Bio-availability.pdfDrug Bio-availability.pdf
Drug Bio-availability.pdf
 
1.0.bioavailability, pharmacokinetics and efficacy determination
1.0.bioavailability, pharmacokinetics and efficacy determination1.0.bioavailability, pharmacokinetics and efficacy determination
1.0.bioavailability, pharmacokinetics and efficacy determination
 

More from Kabin Maleku

Essential Trace elements and Iron.pptx
Essential Trace elements and Iron.pptxEssential Trace elements and Iron.pptx
Essential Trace elements and Iron.pptx
Kabin Maleku
 
Radio pharmaceuticals.pptx
Radio pharmaceuticals.pptxRadio pharmaceuticals.pptx
Radio pharmaceuticals.pptx
Kabin Maleku
 
Filtration and clarification
Filtration and clarificationFiltration and clarification
Filtration and clarification
Kabin Maleku
 
Handling of Gases
Handling of GasesHandling of Gases
Handling of Gases
Kabin Maleku
 
Handling of solids
Handling of solidsHandling of solids
Handling of solids
Kabin Maleku
 
Danphe Covid Care
Danphe Covid CareDanphe Covid Care
Danphe Covid Care
Kabin Maleku
 
Mups tablets
Mups tabletsMups tablets
Mups tablets
Kabin Maleku
 
Topical agents: Inorganic Pharmaceutical Chemistry
Topical agents: Inorganic Pharmaceutical ChemistryTopical agents: Inorganic Pharmaceutical Chemistry
Topical agents: Inorganic Pharmaceutical Chemistry
Kabin Maleku
 
Test of Purity
Test of PurityTest of Purity
Test of Purity
Kabin Maleku
 
Controlled released formulations
Controlled released formulationsControlled released formulations
Controlled released formulations
Kabin Maleku
 
Medicinal Gases and Vapours
Medicinal Gases and VapoursMedicinal Gases and Vapours
Medicinal Gases and Vapours
Kabin Maleku
 
Dental products: Kabin Maleku
Dental products: Kabin MalekuDental products: Kabin Maleku
Dental products: Kabin Maleku
Kabin Maleku
 
Complexing & Chelating agents
Complexing & Chelating agentsComplexing & Chelating agents
Complexing & Chelating agents
Kabin Maleku
 
Acid Base Buffer
Acid Base BufferAcid Base Buffer
Acid Base Buffer
Kabin Maleku
 
UNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESSUNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESS
Kabin Maleku
 
Pulmonary drug delivery
Pulmonary drug deliveryPulmonary drug delivery
Pulmonary drug delivery
Kabin Maleku
 
Pellet technology
Pellet technologyPellet technology
Pellet technology
Kabin Maleku
 
Role of pharmacist
Role of pharmacistRole of pharmacist
Role of pharmacist
Kabin Maleku
 

More from Kabin Maleku (18)

Essential Trace elements and Iron.pptx
Essential Trace elements and Iron.pptxEssential Trace elements and Iron.pptx
Essential Trace elements and Iron.pptx
 
Radio pharmaceuticals.pptx
Radio pharmaceuticals.pptxRadio pharmaceuticals.pptx
Radio pharmaceuticals.pptx
 
Filtration and clarification
Filtration and clarificationFiltration and clarification
Filtration and clarification
 
Handling of Gases
Handling of GasesHandling of Gases
Handling of Gases
 
Handling of solids
Handling of solidsHandling of solids
Handling of solids
 
Danphe Covid Care
Danphe Covid CareDanphe Covid Care
Danphe Covid Care
 
Mups tablets
Mups tabletsMups tablets
Mups tablets
 
Topical agents: Inorganic Pharmaceutical Chemistry
Topical agents: Inorganic Pharmaceutical ChemistryTopical agents: Inorganic Pharmaceutical Chemistry
Topical agents: Inorganic Pharmaceutical Chemistry
 
Test of Purity
Test of PurityTest of Purity
Test of Purity
 
Controlled released formulations
Controlled released formulationsControlled released formulations
Controlled released formulations
 
Medicinal Gases and Vapours
Medicinal Gases and VapoursMedicinal Gases and Vapours
Medicinal Gases and Vapours
 
Dental products: Kabin Maleku
Dental products: Kabin MalekuDental products: Kabin Maleku
Dental products: Kabin Maleku
 
Complexing & Chelating agents
Complexing & Chelating agentsComplexing & Chelating agents
Complexing & Chelating agents
 
Acid Base Buffer
Acid Base BufferAcid Base Buffer
Acid Base Buffer
 
UNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESSUNDERSTANDING GENERIC VS INNOVATOR BUSINESS
UNDERSTANDING GENERIC VS INNOVATOR BUSINESS
 
Pulmonary drug delivery
Pulmonary drug deliveryPulmonary drug delivery
Pulmonary drug delivery
 
Pellet technology
Pellet technologyPellet technology
Pellet technology
 
Role of pharmacist
Role of pharmacistRole of pharmacist
Role of pharmacist
 

Recently uploaded

Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 

Recently uploaded (20)

Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 

In vitro Performance evaluation methods of Tablets

  • 1. PERFORMANCE EVALUATION METHODS In-vitro Dissolution, Bioavailability, Bio equivalence, Evaluation
  • 2. In-vitro dissolution studies Noyes- Whitney Equation Interpretation of Dissolution Data
  • 3. Factors affecting dissolution rate  1. Disintegration is the important first step to drug dissolution in a tablet.  2. Particle size of drug substance.  3. Solubility and hydrophobicity of the drug; type and amount of disintegrant, diluent, binder, lubricant, glidant and the coating type and thickness.  4. Solubility and dissolution also influenced by pH of the media, media composition, change in the crystalinity of drug, temperature, paddle speed.  5. Manufacturing method (compactness of the granulation and compression force used in tableting)
  • 4.
  • 5. Dissolution Apparatus Types: On basis of USP - Similarity and Dissimilarity Factor
  • 6. Dissolution test apparatus Stirrer shaft Paddle Thermostated water bath Glass vessel USP apparatus II
  • 7. Glass vessel 1000 ml volumeCylindrical Stainless steal Basket formed from a screen Paddle (USP apparatus II) Stirrer shaft
  • 8. Stirred vessel method Basket type Paddle type
  • 9. Media used in dissolution test: - Purified water. - Simulated gastric fluid. - Simulated intestinal fluid. - Solvents mixture may be used if the drug solubility is very low.  Dissolution test is performed in-process and on the final product.
  • 10. Bioavailability studies and bioavailability testing protocol and procedures Bioavailability - Bioequivalence
  • 11. Bioavailability Bioavailability is a pharmacokinetic term that describes the rate and extent to which the active drug ingredient is absorbed from a drug product and becomes available at the site of drug action. Why?  Pharmacologic response is generally related to the concentration of drug at the receptor site  Quantity of Drugs in blood/Urine need to be estimated  Assumption- Drug concentration in blood is equivalent to receptor site concentration
  • 12. Absolute Bioavailability  Tofraction of an administered dose which actually reaches the systemic circulation  Denoted by F  Ranges from F = 0 (no drug absorption) to F = 1 (complete drug absorption).
  • 13. Relative Bioavailability  Availability of a drug product as compared to another dosage form or product of the same drug given in the same dose.  The relative bioavailability of product A compared to product B, both products containing the same dose of the same drug, is obtained by comparing their respective
  • 14. Relative Bioavailability  When the bioavailability of a generic product is considered, it is usually the relative bioavailability that is referred to. A more general form of the equation results from considering the possibility of different doses:
  • 16. Factors affecting Bioavaliability  disintegration of the drug product  dissolution of the drug in the fluids at the absorption site  transfer of drug molecule across the membrane lining the gastrointestinal tract into the systemic circulation.
  • 19. Bio-avaliability vs Rate of absorption  aqueous solution > aqueous suspension > capsule> tablet > Controlled Released
  • 20. Methods of assessing bioavailability- Predicting Clinical efficacy  Pharmacokinetics  Pharmacodynamics
  • 21. Methods of assessing bioavailability- Predicting Clinical efficacy  In vivo: Single dose Normal/healthy adult Clinical performance- Large test population Need to be validated,
  • 22. Methods of assessing bioavailability- Predicting Clinical efficacy  Blood sampling Parameters 1. AUC , The area under the plasma concentration-time curve, The AUC is proportional to the total amount of drug reaching the systemic circulation, and thus characterizes the extent of absorption. 2. Cmax , The maximum drug concentration. The maximum concentration of drug in the plasma is a function of both the rate and extent of absorption. Cmax will increase with an increase in the dose, as well as with an increase in the absorption rate. 3. Tmax , The time at which the Cmax occurs. The Tmax reflects the rate of drug absorption, and decreases as the absorption rate increases.
  • 23. Methods of assessing bioavailability- Predicting Clinical efficacy  Urinary Excretion Data -determination of the total quantity of drug excreted in the urine as a function of time - urinary excretion of the unchanged drug is directly proportional to the plasma concentration of total drug. - Consider the following example: two products, A and B, each containing 100 mg of the same drug are administered orally. A total of 80 mg of drug is recovered in the urine from Product A, but only 40 mg is recovered from Product B. This indicates that twice as much drug was absorbed from Product A as from Product B. (The fact that neither product resulted in excretion of the entire dose might be due to the existence of other routes of elimination, e.g. metabolism).
  • 24. Methods of assessing bioavailability- Predicting Clinical efficacy  Urinary Excretion Data 1. the fraction of drug entering the bloodstream and being excreted intact by the kidneys must remain constant. 2. collection of the urine has to continue until all the drug has been completely excreted (five times the half-life ).
  • 25. Parameters for Urinary Excretion 1. Maximum urinary excretion rate 2. Time for Maximum excretion rate 3. Cumulative amount of Drug excreted
  • 26.  The assessment o bioavailability by urinary excretion is based on the assumption that the appearance of the drug and/ or its metabolites in the urine is a function of the rate and extent o absorption. This assumption is only valid when a drug and/ or its metabolites are extensively excreted in the urine, and where the rate of urinary excretion is proportional to the concentration o the intact drug in the blood plasma.
  • 28. This proportionality does not hold if:  the drug and/ or its metabolites are excreted by an active transport process into the distal kidney tubule  the intact drug and/ or its metabolites are weakly acidic or weakly basic (i.e. their rate of excretion is dependent on urine pH)  the excretion rate depends on the rate o urine flow.
  • 29. Interpretation: Plasma concentration-time curves for three different formulations of the same drug administered in equal single doses by the same extravascular route.
  • 31. Biopharmaceutics Classification System  Class I – high solubility/ high permeability  Class II – low solubility/ high permeability  Class III – high solubility/ low permeability  Class IV – low solubility/ low permeability.